Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds. - Wikidata - awgldk - TriplyDB

Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds.

Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds.

http://www.wikidata.org/entity/Q38168505

about

Herbal medicines and nonalcoholic fatty liver disease Epigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutrition Mediterranean diet and nonalcoholic fatty liver disease: molecular mechanisms of protection.Potential epigenetic mechanism in non-alcoholic Fatty liver disease Carotenoids and non-alcoholic fatty liver disease.Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid β-oxidation Paediatric non-alcoholic fatty liver disease: an overview.Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives.Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver Diseases.Non-alcoholic Fatty Liver Disease: Beneficial Effects of Flavonoids.Chemoprevention of obesity by dietary natural compounds targeting mitochondrial regulation.Rimonabant Improves Oxidative/Nitrosative Stress in Mice with Nonalcoholic Fatty Liver Disease.Amelioration of free fatty acid-induced fatty liver by quercetin-3-O-β-D-glucuronide through modulation of peroxisome proliferator-activated receptor-alpha/sterol regulatory element-binding protein-1c signaling.Calebin-A inhibits adipogenesis and hepatic steatosis in high-fat diet-induced obesity via activation of AMPK signaling.Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis.Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial.Potential Biological Effects of (-)-Epigallocatechin-3-gallate on the Treatment of Nonalcoholic Fatty Liver Disease.Combination of citrus polymethoxyflavones, green tea polyphenols, and Lychee extracts suppresses obesity and hepatic steatosis in high-fat diet induced obese mice.Lycopene and tomato powder supplementation similarly inhibit high-fat diet induced obesity, inflammatory response, and associated metabolic disorders.The effect of minimal dietary changes with raisins in NAFLD patients with non-significant fibrosis: a randomized controlled intervention.

P2860

Q26738524-E3FF3C5B-D0C2-4F22-B62F-D30050CF5F7E Q26822513-907174E0-04AD-4316-8CE6-A5B97CD09929 Q30248650-3366330F-B30D-4EE6-AEC0-6C62E71CC71A Q35380845-53CD6CE6-4C4E-4824-8EAA-2A688A40DE71 Q35737427-E2C15F3F-0F7C-4D25-B11F-FD3A061330BC Q37244257-B02A3676-C18A-4E16-9A50-73DDC55EC812 Q38370919-E6554795-85C3-4B4F-A6C2-8F123BA8764F Q38599131-1C8E0B9F-650F-4167-A8E2-1CD3BE6EAB56 Q38819558-E3AD8CE4-9622-45D3-8CAC-3035CF33A614 Q38866384-2211F3C6-3B28-4B07-B897-D190E3CCFDFA Q39012540-FC38C735-452F-4522-B240-FC5F82BDAE45 Q41008505-ADA3B201-F383-4EAD-B4FD-08D56A181401 Q42701165-1D8B9056-15B1-4633-866E-D0A4D3033F71 Q42825794-A1C707CA-BFFE-45F7-9B40-62D4A6FB3950 Q46554515-9AC4730F-B9CA-4D0F-B7C3-49EE7CCC7F83 Q47192103-6DDC527C-0488-43F3-9CB9-348B13776E0A Q50194612-455F2B59-6E3B-4D92-8B90-3F6686C70105 Q50198183-B49AFDA4-7B94-45B4-ADF4-43176AD0BA1F Q51108425-A49E2F7C-F41C-4F25-A19E-58D08895BD43 Q51278231-D82C6B31-5F8C-4D6E-8B22-F916226834EC

P2860

Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds.

http://www.wikidata.org/entity/Q38168505

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds.

@en

type

label

Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds.

@en

prefLabel

Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds.

@en

P1433

Q38168505-F5EAB5CF-B39C-4070-BD9D-757CA9770BEB

P1476

Q38168505-0AD0B829-AF9F-4D37-B242-FCCCB80CC0D4

P2093

Q38168505-5F4E4438-F3FE-42EA-9CE9-CA749AE7F97F

Q38168505-7DE4C57B-449A-4CDA-9E97-581A99967BCF

Q38168505-E3B97E1B-85B3-4CE2-A804-905B965E9D71

P2860

Q38168505-00EC9239-17C8-4CE4-B763-BF17CF430ECB

Q38168505-0141B1BB-2FA6-4BFD-9069-F9857B345298

Q38168505-017AAFDC-D029-48D8-AF45-009AA4BE5887

Q38168505-043740B8-FD61-4AAA-B801-AAA725C72BC5

Q38168505-04E44BA5-F0B5-49CE-BF56-ADA45E77990C

Q38168505-06002584-3818-4F63-BB23-DB5FCC702116

Q38168505-0709C1E3-7185-4B1E-83CA-13851AD8DC74

Q38168505-079E5740-A5D3-4A05-A66D-1830AF0BF151

Q38168505-08266F09-634D-4D4E-B0DC-608E83F88EF9

Q38168505-083B3AF0-B4D7-4291-B243-3A89E90AD9E4

P304

Q38168505-60C32327-BEAF-4C3F-A181-9CDD4B93CE0C

P31

Q38168505-C8190A2E-B24D-4BB6-9D8B-0D6DADD5AA3C

P356

Q38168505-4AA1C3BE-BFEF-4A10-A9B6-B23D893CB91C

P433

Q38168505-4DDD9FA3-90DC-46FB-B05A-64545B4012A6

P478

Q38168505-EB99B05C-F77D-4BD0-87C1-ACE037F58E72

P50

Q38168505-36FB39E5-2354-4E8A-B3B8-CC62F7D43F30

P577

Q38168505-BD97976F-F15C-482C-B8BC-1C2EAFC75C0F

P698

Q38168505-3A27C983-D921-4B09-8BC7-2A3E53564F3F

P356

P1433

Molecular Nutrition and Food Research

P1476

Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds

@en

P2093

Chi-Tang Ho

http://www.w3.org/2001/XMLSchema#string

Ching-Shu Lai

http://www.w3.org/2001/XMLSchema#string

Mei-Ling Tsai

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10

Insulin signalling and the regulation of glucose and lipid metabolism

Endoplasmic reticulum stress and the inflammatory basis of metabolic disease

Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance

Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2

The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease

Mechanisms of fatty acid-induced inhibition of glucose uptake

Curcumin prevents leptin raising glucose levels in hepatic stellate cells by blocking translocation of glucose transporter-4 and increasing glucokinase

P304

147-171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MNFR.201300522

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24302567

http://www.w3.org/2001/XMLSchema#string